Radioguided excision of the nonpalpable breast cancer and simultaneous sentinel lymphnode biopsy using a single radiopharmaceutical: An original approach to accurate administration of the blue dye

Journal of Surgical Oncology

Volumn 83, Issue 1, 2003, Pages 48-50

  Žgajnar, Janez ^a   Bešič, Nikola ^a   Frkovič Grazio, Snježana ^a   Hočevar, Marko ^a   Vidergar, Barbara ^a   Rener, Miljeva ^a   Lindtner, Jurij ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

BLUE DYE; BLUE PANTENE V; DYE; NANOCOL; NANOCOLL TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCINTISCANNING; DIAGNOSTIC ACCURACY; ECHOGRAPHY; EXCISION; HUMAN; IMAGING SYSTEM; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; METASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; STEREOTAXIC SURGERY;

BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0037625858     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10232     Document Type: Article

References (11)

1. Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398.
2. Krag DN, Weaver DL, Alex JC, et al.: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-339.
3. Albertini JJ, Lyman GH, Cox C, et al.: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822.
4. Cody HS III: "Sentinel lymphnode biopsy." London: Martin Dunitz; 2002.
5. Luini A, Zurrida S, Paganelli G, et al.: Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg 1999;86:522-525.
6. Gennari R, Galimberti V, De Cicco C, et al.: Use of technetium-99m-labeled colloid albumin for preoperative and intraoperative localization of nonpalpable breast lesions. J Am Coll Surg 2000;190:692-698.
7. Wilhelm AJ, Mijnhout GS, Franssen EJ: Radiopharmaceuticals in sentinel lymph-node detection - An overview. Eur J Nucl Med 1999;26:S36-S42.
8. Gray RJ, Giuliano R, Dauway EL, et al.: Radioguidance for nonpalpable primary lesions and sentinel lymph node(s). Am J Surg 2001;182:404-406.
9. Feggi L, Basaglia E, Corcione S, et al.: An original approach in the diagnosis of early breast cancer: Use of the same radio-pharmaceutical for both non-palpable lesions and sentinel node localisation. Eur J Nucl Med 2001;28:1589-1596.
10. Tanis PJ, Deurloo EE, Valdes Olmos RA, et al.: Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node. Ann Surg Oncol 2001;8:850-855.
11. Jansen L, Doting MH, Rutgers EJ, et al.: Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 2000;87:920-925.